⌘K

Home/Filings/4/0000899243-18-017187

4//SEC Filing

Baltzell Joshua J 4

Accession 0000899243-18-017187

CIK 0001372299other

View on SEC.gov Company Profile

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 4:41 PM ET

Size

5.3 KB

Accession

0000899243-18-017187

Insider Transaction Report

Form 4

Period: 2018-06-15

HISTOGENICS CORPHSGX

Baltzell Joshua J

Director

Transactions

Award
Stock Option (Right to Buy)
2018-06-15+25,000→ 25,000 total
Exercise: $2.97Exp: 2028-06-14→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable with respect to 8.33% of the option shares for each one-month period following June 15, 2018.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

HISTOGENICS CORP

CIK 0001372299

Entity typeother

Related Parties

1

filerCIK 0001418439

Filing Metadata

Form type: 4
Filed: Jun 18, 8:00 PM ET
Accepted: Jun 19, 4:41 PM ET
Size: 5.3 KB

View on SEC.gov